HER2-targeted star polymer conjugates for improved tumor distribution and efficacy

Area of Science:

• Nanotechnology
• Materials Science
• Oncology

Background:

• Actively targeted nanoparticle systems offer potential for improved tumor drug delivery compared to untargeted systems.
• Design principles for optimizing targeted delivery remain an area of active research.
• Understanding receptor-mediated targeting is crucial for enhancing therapeutic outcomes.

Purpose of the Study:

• To investigate the efficacy of a HER2-targeted polymer drug delivery system (HER2-SD) for targeting cancer cells overexpressing HER2.
• To evaluate the impact of HER2-targeted star polymers on in vitro binding, in vivo biodistribution, tumor penetration, and anti-tumor activity.
• To compare the performance of HER2-targeted star polymers at different HER2-Fab densities against non-targeted controls.

Main Methods:

• Synthesis of a 32-arm star polymer (SD) conjugated with SN-38 (TOP1 inhibitor) and varying densities of trastuzumab antigen-binding fragment (HER2-Fab).
• In vitro assessment of binding and uptake in HER2-positive cell lines (SK-BR3, HEK293).
• In vivo biodistribution studies in tumor-bearing mice, tumor penetration analysis, and anti-tumor efficacy testing in a HER2-positive gastric cancer xenograft model.

Main Results:

• HER2-targeted star polymers (HER2-SDs) exhibited superior binding and uptake in HER2-positive cell lines compared to non-targeted SDs.
• In vivo studies revealed enhanced accumulation of HER2-SDs in tumors, with improved localization, tumor core penetration, and homogenous distribution, particularly at 96 hours post-dose.
• The targeted star polymer SN-38 conjugate demonstrated significantly greater anti-tumor efficacy in a HER2-positive gastric cancer xenograft model than untargeted SDs.

Conclusions:

• HER2-targeted star polymers effectively target HER2-overexpressing cancer cells and enhance drug delivery to tumors.
• The design of targeted nanoparticles can significantly improve tumor accumulation, penetration, and therapeutic efficacy.
• This study provides valuable insights into the design rules for actively targeted nanoparticle systems for cancer therapy.